• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药用化学策略在生物活性天然产物修饰中的应用。

Medicinal Chemistry Strategies for the Modification of Bioactive Natural Products.

机构信息

Shenzhen Borui Pharmaceutical Technology Co., Ltd., Shenzhen 518055, China.

Medi-X Pingshan, Southern University of Science and Technology, Shenzhen 518055, China.

出版信息

Molecules. 2024 Feb 2;29(3):689. doi: 10.3390/molecules29030689.

DOI:10.3390/molecules29030689
PMID:38338433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10856770/
Abstract

Natural bioactive compounds are valuable resources for drug discovery due to their diverse and unique structures. However, these compounds often lack optimal drug-like properties. Therefore, structural optimization is a crucial step in the drug development process. By employing medicinal chemistry principles, targeted molecular operations can be applied to natural products while considering their size and complexity. Various strategies, including structural fragmentation, elimination of redundant atoms or groups, and exploration of structure-activity relationships, are utilized. Furthermore, improvements in physicochemical properties, chemical and metabolic stability, biophysical properties, and pharmacokinetic properties are sought after. This article provides a concise analysis of the process of modifying a few marketed drugs as illustrative examples.

摘要

天然生物活性化合物因其多样且独特的结构而成为药物发现的宝贵资源。然而,这些化合物往往缺乏理想的药物样特性。因此,结构优化是药物开发过程中的关键步骤。通过运用药物化学原理,可以针对天然产物进行靶向分子操作,同时考虑其大小和复杂性。各种策略,包括结构碎片化、去除冗余原子或基团,以及探索结构-活性关系,都被应用。此外,还致力于改善物理化学性质、化学和代谢稳定性、生物物理性质以及药代动力学性质。本文通过简要分析几个已上市药物的修饰过程,为您提供示例说明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/e7688fd7a918/molecules-29-00689-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/ddbcff3f9488/molecules-29-00689-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/4734cc734055/molecules-29-00689-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/75c671c66d6a/molecules-29-00689-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/727fa8a91732/molecules-29-00689-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/8e070b0c8f68/molecules-29-00689-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/456e57bd5b3f/molecules-29-00689-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/e2e7eb3ac826/molecules-29-00689-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/0c9278985162/molecules-29-00689-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/47c6e83e6899/molecules-29-00689-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/bcea90b39bde/molecules-29-00689-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/7be4665cc3d3/molecules-29-00689-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/ec01cd56f253/molecules-29-00689-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/ee0905710338/molecules-29-00689-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/e7688fd7a918/molecules-29-00689-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/ddbcff3f9488/molecules-29-00689-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/4734cc734055/molecules-29-00689-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/75c671c66d6a/molecules-29-00689-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/727fa8a91732/molecules-29-00689-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/8e070b0c8f68/molecules-29-00689-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/456e57bd5b3f/molecules-29-00689-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/e2e7eb3ac826/molecules-29-00689-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/0c9278985162/molecules-29-00689-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/47c6e83e6899/molecules-29-00689-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/bcea90b39bde/molecules-29-00689-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/7be4665cc3d3/molecules-29-00689-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/ec01cd56f253/molecules-29-00689-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/ee0905710338/molecules-29-00689-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/10856770/e7688fd7a918/molecules-29-00689-g014.jpg

相似文献

1
Medicinal Chemistry Strategies for the Modification of Bioactive Natural Products.药用化学策略在生物活性天然产物修饰中的应用。
Molecules. 2024 Feb 2;29(3):689. doi: 10.3390/molecules29030689.
2
Structural Simplification of Natural Products.天然产物的结构简化。
Chem Rev. 2019 Mar 27;119(6):4180-4220. doi: 10.1021/acs.chemrev.8b00504. Epub 2019 Feb 7.
3
Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.优化天然抗癌先导化合物或候选药物的策略。
Med Res Rev. 2016 Jan;36(1):32-91. doi: 10.1002/med.21377. Epub 2015 Sep 11.
4
Insights into drug discovery from natural products through structural modification.通过结构修饰从天然产物中洞察药物发现
Fitoterapia. 2015 Jun;103:231-41. doi: 10.1016/j.fitote.2015.04.012. Epub 2015 Apr 24.
5
The quest for supernatural products: the impact of total synthesis in complex natural products medicinal chemistry.对超自然产物的追求:全合成对复杂天然产物药物化学的影响。
Nat Prod Rep. 2020 Nov 1;37(11):1511-1531. doi: 10.1039/d0np00060d. Epub 2020 Nov 10.
6
Novel chemical space exploration via natural products.通过天然产物进行新型化学空间探索。
J Med Chem. 2009 Apr 9;52(7):1953-62. doi: 10.1021/jm801514w.
7
Into the Fray! A Beginner's Guide to Medicinal Chemistry.《战火纷飞!药用化学初学者指南》。
ChemMedChem. 2021 Apr 20;16(8):1199-1225. doi: 10.1002/cmdc.202000929. Epub 2021 Feb 16.
8
Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry.通过骨架跃迁方法得到的天然生物活性黄酮类化合物的生物电子等排体杂环类似物:药物化学的现状与展望
Bioorg Med Chem. 2024 Jul 15;109:117791. doi: 10.1016/j.bmc.2024.117791. Epub 2024 Jun 8.
9
Considerations of the chemical biology of microbial natural products provide an effective drug discovery strategy.考虑微生物天然产物的化学生物学为药物发现提供了一种有效的策略。
Arch Pharm Res. 2015 Sep;38(9):1591-605. doi: 10.1007/s12272-015-0639-y. Epub 2015 Aug 1.
10
Studies on Comprehensive Total Synthesis of Natural and Pseudo-Natural Products for Drug Discovery.天然和伪天然产物的综合全合成用于药物发现的研究。
Chem Pharm Bull (Tokyo). 2024;72(5):422-431. doi: 10.1248/cpb.c24-00056.

引用本文的文献

1
Therapeutic interventions aimed at cccDNA: unveiling mechanisms and evaluating the potency of natural products.针对cccDNA的治疗干预措施:揭示作用机制并评估天然产物的效力
Front Cell Infect Microbiol. 2025 Jun 17;15:1598872. doi: 10.3389/fcimb.2025.1598872. eCollection 2025.
2
Arene Substitutions in Orchid Bibenzyls: Mechanistic Insights into Glucose Uptake and Lipid Metabolism for Targeting Metabolic Disorders.兰花联苄中的芳烃取代:针对代谢紊乱的葡萄糖摄取和脂质代谢的机制洞察
Nutrients. 2025 Mar 21;17(7):1104. doi: 10.3390/nu17071104.
3
Apigenin-mediated MARK4 inhibition: a novel approach in advancing Alzheimer's disease therapeutics.

本文引用的文献

1
Metapangenomics of wild and cultivated banana microbiome reveals a plethora of host-associated protective functions.野生和栽培香蕉微生物组的宏泛基因组学揭示了大量与宿主相关的保护功能。
Environ Microbiome. 2023 Apr 21;18(1):36. doi: 10.1186/s40793-023-00493-x.
2
Opinion: Protein folds vs. protein folding: Differing questions, different challenges.观点:蛋白质折叠结构与蛋白质折叠过程:不同的问题,不同的挑战。
Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2214423119. doi: 10.1073/pnas.2214423119. Epub 2022 Dec 29.
3
What's next for AlphaFold and the AI protein-folding revolution.
芹菜素介导的MARK4抑制作用:推进阿尔茨海默病治疗的新方法。
Mol Divers. 2025 Jan 22. doi: 10.1007/s11030-025-11104-x.
4
Synergistic attenuation of complete freund's adjuvant-induced inflammation in mice using shinbaro-pelubiprofen: a novel therapeutic complex.使用信保洛非布芬协同减轻小鼠完全弗氏佐剂诱导的炎症:一种新型治疗复合物
Mol Med. 2025 Jan 21;31(1):17. doi: 10.1186/s10020-025-01083-y.
5
New Phytol Derivatives with Increased Cosmeceutical Potential.具有增强化妆品潜力的新植物衍生物。
Molecules. 2024 Oct 17;29(20):4917. doi: 10.3390/molecules29204917.
6
Cucurbitacin B and Its Derivatives: A Review of Progress in Biological Activities.葫芦素 B 及其衍生物:生物活性研究进展综述。
Molecules. 2024 Sep 4;29(17):4193. doi: 10.3390/molecules29174193.
7
Palladium-Catalyzed Tsuji-Trost-Type Reaction of 3-Indolylmethylacetates with O, and S Soft Nucleophiles.钯催化3-吲哚基甲基乙酸酯与氧和硫软亲核试剂的Tsuji-Trost型反应
Molecules. 2024 Jul 22;29(14):3434. doi: 10.3390/molecules29143434.
8
Investigating the potential of mono-chalcone compounds in targeting breast cancer receptors through network pharmacology, molecular docking, molecular dynamics simulation, antiproliferative effects, and gene expressions.通过网络药理学、分子对接、分子动力学模拟、抗增殖作用和基因表达来研究单查尔酮化合物作用于乳腺癌受体的潜力。
3 Biotech. 2024 Jun;14(6):151. doi: 10.1007/s13205-024-03991-y. Epub 2024 May 10.
9
NIMO: A Natural Product-Inspired Molecular Generative Model Based on Conditional Transformer.NIMO:一种基于条件变换器的受天然产物启发的分子生成模型。
Molecules. 2024 Apr 19;29(8):1867. doi: 10.3390/molecules29081867.
AlphaFold和人工智能蛋白质折叠革命的下一步是什么。
Nature. 2022 Apr;604(7905):234-238. doi: 10.1038/d41586-022-00997-5.
4
The protein-folding problem: Not yet solved.蛋白质折叠问题:尚未解决。
Science. 2022 Feb 4;375(6580):507. doi: 10.1126/science.abn9422. Epub 2022 Feb 3.
5
Structural basis of inhibition of the human SGLT2-MAP17 glucose transporter.人SGLT2-MAP17葡萄糖转运蛋白抑制作用的结构基础
Nature. 2022 Jan;601(7892):280-284. doi: 10.1038/s41586-021-04212-9. Epub 2021 Dec 8.
6
Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition.脂质受体 S1PR1 和 S1PR5 的信号复合物结构揭示了激活和药物识别的机制。
Cell Res. 2021 Dec;31(12):1263-1274. doi: 10.1038/s41422-021-00566-x. Epub 2021 Sep 15.
7
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
8
Use of artificial intelligence to enhance phenotypic drug discovery.利用人工智能增强表型药物发现。
Drug Discov Today. 2021 Apr;26(4):887-901. doi: 10.1016/j.drudis.2021.01.013. Epub 2021 Jan 20.
9
The birth of artemisinin.青蒿素的诞生。
Pharmacol Ther. 2020 Dec;216:107658. doi: 10.1016/j.pharmthera.2020.107658. Epub 2020 Aug 8.
10
A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis.一项评估罗沙司他间歇口服给药治疗未接受透析的非透析慢性肾脏病且对红细胞生成刺激剂初治的日本贫血患者的 3 期、多中心、随机、双盲、开放性研究
Nephron. 2020;144(8):372-382. doi: 10.1159/000508100. Epub 2020 Jun 24.